Quality of life with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: quality of life analysis of TORG 0503-Reference-Cited by-同舟云学术

Quality of life with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: quality of life analysis of TORG 0503

Published:2023-05-01 Issue:9 Volume:32 Page:2629-2637
ISSN:0962-9343
Container-title:Quality of Life Research
language:en
Short-container-title:Qual Life Res

Author:

Matsuda Ayako^ORCID,Yamaoka Kazue,Kunitoh Hideo,Seto Takashi,Tsuboi Masahiro,Ohira Tatsuo,Maruyama Riichiroh,Okamoto Hiroaki,Kubota Kaoru

Funder

Ministry of Education

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

https://link.springer.com/content/pdf/10.1007/s11136-023-03424-y.pdf

Reference25 articles.

1. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660

2. Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022). Cancer statistics, 2022. CA: A Cancer Journal for Clinicians, 72(1), 7–33. https://doi.org/10.3322/caac.21708

3. Testa, U., Castelli, G., & Pelosi, E. (2018). Lung cancers: Molecular characterisation, clonal heterogeneity and evolution, and cancer stem cells. Cancers, 10(8), 248. https://doi.org/10.3390/cancers10080248

4. Jones, G. S., & Baldwin, D. R. (2018). Recent advances in the management of lung cancer. Clinical Medicine, 18(Suppl 2), s41–s46. https://doi.org/10.7861/clinmedicine.18-2-s41

5. Fossella, F., Pereira, J. R., von Pawel, J., Pluzanska, A., Gorbounova, V., Kaukel, E., Mattson, K. V., Ramlau, R., Szczesna, A., Fidias, P., Millward, M., & Belani, C. P. (2003). Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 Study Group. Journal of Clinical Oncology, 21(16), 3016–3024. https://doi.org/10.1200/JCO.2003.12.046